GradedHealth

Does daily melatonin stop your body from making its own?

Daily melatonin does not stop your body from making its own hormone. Clinical trials show no signs of tolerance, physical dependence, or rebound insomnia.

Published October 2026

Short answer

No. Clinical trials show daily melatonin does not suppress your pineal gland's natural production, nor does it cause physical dependence, tolerance, or rebound insomnia when stopped. Evidence grade B (Moderate). Randomised controlled trials and crossover studies in humans; downgraded for small direct-hormone sample sizes.

Key takeaways

  • Taking melatonin daily does not shut down your pineal gland's natural hormone production [1].
  • In a six-month randomised trial of 746 adults, daily melatonin caused no tolerance, physical dependence, or withdrawal symptoms upon stopping [2].
  • Unlike prescription sedatives, discontinuing melatonin does not trigger rebound insomnia or worsening of sleep [3] [4].
  • A physiological dose of 0.3 mg elevates melatonin to normal nighttime levels, whereas 3 mg leaves blood levels elevated into daytime [5].
  • Meta-analyses of randomised trials show melatonin modestly reduces sleep onset latency by about 7 minutes [6].

The short version

Taking Melatonin every night does not shut down your body's ability to produce the hormone naturally [1]. Unlike steroid hormones or prescription sleeping pills, melatonin synthesis is governed by light exposure rather than a circulating negative feedback loop [7]. Long-term trials demonstrate that stopping melatonin does not cause physical dependence, tolerance, or rebound insomnia [2].

What the studies show

Concerns about dependence stem from how the body handles other hormones, such as cortisol or testosterone, where external supplementation signals the gland to shut down production [7]. The pineal gland does not operate on this kind of negative feedback loop [7]. In a double-blind crossover trial where volunteers took 2 mg of melatonin daily for up to one month, endogenous melatonin rhythms and pituitary hormones remained entirely unaffected after discontinuation [1].

Clinical trials also confirm an absence of physical dependence and withdrawal symptoms [4]. In a randomised, double-blind trial following 746 adults with primary insomnia over six months, daily treatment with 2 mg of prolonged-release melatonin showed no loss of efficacy and no evidence of tolerance [2]. When patients stopped the supplement during a two-week placebo run-out period, researchers recorded no withdrawal symptoms and no rebound insomnia [2]. A shorter three-week trial similarly showed no worsening of sleep or rebound effects following abrupt cessation [3]. Across pooled clinical trials, melatonin produces modest benefits, shortening sleep onset latency by approximately 7 minutes without losing efficacy over time [6].

The nuances

Dosing makes a substantial difference in how melatonin behaves in the body [5]. The pineal gland naturally produces less than 100 micrograms of melatonin each night [4]. In controlled trials, a physiological dose of 0.3 mg restored normal nocturnal blood concentrations in adults with insomnia [5]. By contrast, a common commercial dose of 3 mg elevated circulating concentrations to supra-physiological levels that persisted into daytime hours and lowered body temperature [5].

Safety reviews show that oral melatonin has a favourable safety profile, but higher doses frequently cause morning drowsiness, headache, and dizziness [8] [4]. Prolonged-release formulations mimic the body's natural nocturnal curve more closely than immediate-release tablets, especially in older adults whose nighttime secretion has declined [3] [2]. See the Melatonin topic page for complete safety details, interactions, and contraindications.

What this means for you

If you take melatonin for occasional sleep difficulties or jet lag, you do not need to worry that you are disabling your body's internal clock [1] [2]. You can stop taking it without tapering, as clinical trials show no physiological withdrawal or rebound insomnia [2].

If you choose to use melatonin, consider starting with the lowest effective dose, such as 0.3 mg to 1 mg, taken 30 to 60 minutes before bedtime [5]. Avoid treating melatonin as a heavy sedative; it acts primarily as a circadian darkness signal rather than an instant sleep-inducing drug [7]. Anyone with autoimmune conditions, liver disease, or who is pregnant should speak with a doctor before supplementing [8].

Go deeper

  • Melatonin — Melatonin modestly reduces the time it takes to fall asleep, by about 7 minutes across 19 trials.

References

  1. The effects of exogenous melatonin on endocrine function in man.. Clin Endocrinol (Oxf), 1986.
  2. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.. Curr Med Res Opin, 2011.
  3. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.. Curr Med Res Opin, 2007.
  4. Current Insights into the Risks of Using Melatonin as a Treatment for Sleep Disorders in Older Adults.. Clin Interv Aging, 2023.
  5. Melatonin treatment for age-related insomnia.. J Clin Endocrinol Metab, 2001.
  6. Meta-analysis: melatonin for the treatment of primary sleep disorders.. PLoS One, 2013.
  7. Melatonin: Physiological effects in humans.. Neurochirurgie, 2015.
  8. Adverse events associated with oral administration of melatonin: A critical systematic review of clinical evidence.. Complement Ther Med, 2019.